Andreas Funke

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst et al. · The Lancet Neurology · 2018 · 78 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Medicine +5

Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

Christoph Neuwirth, Nathalie Braun, Kristl G. Claeys et al. · Clinical Neurophysiology · 2018 · 62 citations

Kinesiology, Health Sciences, Motor Control +7

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Thomas Meyer, Andreas Funke, Christoph Münch et al. · BMC Neurology · 2019 · 60 citations · Full text

Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach

Andreas Funke, Susanne Spittel, Torsten Grehl et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2018 · 50 citations